Leukapheresis Market Size

Leukapheresis Market size is anticipated to reach USD 8 Billion by the end of 2036, growing at a CAGR of 6% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of leukapheresis was USD 1 Billion. The demand for leukapheresis is driven by an increasing incidence of leukemia, as leukapheresis is a critical medical procedure to trealeukemia. As per a report, in 2023, there will be 1,958,310 new cancer cases diagnosed in the US; of these, leukemia, lymphoma, and myeloma cases are predicted to make up 9.4%. Leukapheresis is a procedure to remove white blood cells that may be used for other medical purposes, such as stem cell transplantation and immunotherapy. The need for leukapheresis to support these treatments is increasing as the incidence of leukemia increases, and this has led to an increase in sales.

Leukapheresis can be performed to harvest stem cells from children for other cancer patients as well as to treat or eliminate excess WBCs in children with lymphoma. Leukapheresis is a market focus because of its potential and advantages in this application, particularly as children's leukapheresis treatment is now only available in a small number of hospitals in developed and developing nations. Therefore, this factor is propelling the growth of the leukapheresis market.